Vijaya Diagnostic Centre Limited
₹1,447.25-₹17.40 (-1.2%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹10,297 Cr
- P/E
- 69.2x
- EV / EBITDA
- 45.6x
- Revenue
- ₹627 Cr
- Net margin
- 21.9%
- ROCE
- 23.5%
Price chart
Technical chartScreen technicals →+45.5% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- +0.8%
- 3M
- +6.4%
- 6M
- +28.4%
- 1Y
- +45.5%
- 5Y
- +158.6%
52-week range
Day change -₹17.40 (-1.2%) from ₹1,465 to ₹1,447 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in VIJAYA, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Healthy return on equity of 17.6%
Concerns0
Rule-based from financial data. Not advice.
About the company
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
- Sector
- Healthcare
- Shares outstanding
- 10.3 Cr shares
- ISIN
- INE043W01024
- BSE code
- 543350
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹10,297 Cr
- P/E
- 69.2x
- P/B
- 12.1x
- EV / EBITDA
- 45.6x
- EV / Sales
- 20.0x
- P/S
- 19.6x
- Earnings yield
- 1.4%
- 52-week high
- ₹1,567.85
- 52-week low
- ₹861.45
Profitability
- Operating margin
- 40.4%
- Net margin
- 21.9%
- EBITDA margin
- 44.0%
- ROE
- 17.6%
- ROCE
- 23.5%
- ROA
- 12.0%
- Dividend payout
- 9.0%
- Tax rate
- 25.0%
- Other income, % of PBT
- 12.5%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹627 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 19.4%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 9.8%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹231 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 19.1%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 17.4%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 13.5%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹175 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 7.4%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -₹6.00 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 13.2%
Solvency and efficiency
- Current ratio
- 6.29
- Debt / Equity
- 0.38
- Debt / Assets
- 0.26
- Debt / EBITDA
- 1.08
- Interest coverage
- 8.83
- Financial leverage
- 1.47
- CFO / Net profit
- 1.52
- Cash / Market cap
- 1.1%
- Cash per share
- ₹11.35
- Asset turnover
- 0.55
- Fixed asset turnover
- 0.90
- Capital intensity
- 1.11
- Debtor days
- 9 days
- Inventory turnover
- 14.04
- Cash conversion cycle
- -143 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹22 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹374 Cr |
| Sales | Operating profit | ₹253 Cr |
| Operating profit | Interest | ₹25 Cr |
| Operating profit | Depreciation | ₹65 Cr |
| Operating profit | Profit before tax | ₹163 Cr |
| Other income | Profit before tax | ₹18 Cr |
| Profit before tax | Tax and other | ₹46 Cr |
| Profit before tax | Net profit | ₹135 Cr |
Revenue and net profit
Revenue grew 19.4% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹367 Cr | ₹83 Cr |
| FY2022 | ₹451 Cr | ₹108 Cr |
| FY2023 | ₹450 Cr | ₹83 Cr |
| FY2024 | ₹525 Cr | ₹115 Cr |
| FY2025 | ₹627 Cr | ₹135 Cr |
Cash flows
FY2025: ₹207 Cr from operations, ₹42.0 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹128 Cr | -₹1 Cr |
| FY2022 | ₹155 Cr | ₹28 Cr |
| FY2023 | ₹163 Cr | ₹55 Cr |
| FY2024 | ₹175 Cr | ₹36 Cr |
| FY2025 | ₹207 Cr | ₹42 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹627 Cr+19.4%1Y
- Net profit
- ₹135 Cr+17.4%1Y
- Cash from operations
- ₹207 Cr
- Free cash flow
- ₹42 Cr+16.7%1Y
- Revenue CAGR, 5Y
- 9.8%
- EBITDA CAGR, 5Y
- 9.8%
- Net profit CAGR, 5Y
- 13.5%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹627 Cr | ₹253 Cr | — | ₹135 Cr | ₹207 Cr | ₹42 Cr | 17.2% | +19.4% | +17.4% |
Monthly returns
Month-by-month returns of VIJAYA across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹1,224 Cr |
| Equity capital | ₹10 Cr |
| Reserves | ₹773 Cr |
| Borrowings | ₹292 Cr |
| Other liabilities | ₹148 Cr |
| Assets | ₹1,224 Cr |
| Fixed assets | ₹672 Cr |
| Capital work in progress | ₹67 Cr |
| Investments | ₹328 Cr |
| Other assets | ₹157 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
VIJAYA trades at 69.2x earnings against a peer median of 52.6x (a 32% premium).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre LimitedVIJAYAthis companyP/E ↑ premium | ₹10,297 Cr | 69.2x | 12.1x | 17.6% | 45.6x |
| RUBICON RESEARCH LIMITEDRUBICON | ₹11,141 Cr | 65.0x | — | 5.0% | 115.2x |
| ALIVUS LIFE SCIENCES LIMITEDALIVUS | ₹10,777 Cr | 20.3x | 3.6x | 20.2% | 15.2x |
| Metropolis Healthcare LimitedMETROPOLIS | ₹9,882 Cr | 74.0x | 7.4x | 11.3% | 36.5x |
| Sanofi Consumer Healthcare India LimitedSANOFICONR | ₹9,742 Cr | 45.3x | 37.8x | — | — |
| JYOTHY LABS LIMITEDJYOTHYLAB | ₹9,555 Cr | 27.2x | 6.6x | 32.4% | 17.6x |
| HealthCare Global Enterprises LimitedHCG | ₹9,408 Cr | 513.0x | 8.0x | 2.8% | 49.9x |
| Sanofi India LtdSANOFI | ₹9,387 Cr | 25.4x | 12.0x | — | — |
| Jeena Sikho Lifecare LimitedJSLL | ₹8,968 Cr | 58.2x | 25.2x | 35.9% | 90.3x |
| Peer median | — | 52.6x | 5.9x | 12.1% | 38.3x |
Year-to-date ROI
VIJAYA since 1 January, against earlier years.
Historical volatility
VIJAYA's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 44.0% |
| FY2022 | 44.0% |
| FY2023 | 40.0% |
| FY2024 | 40.0% |
| FY2025 | 40.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹627 Cr |
| Costs | |
| Interest | ₹25 Cr |
| Expenses | ₹374 Cr |
| Operating profitOperating Profit | ₹253 Cr |
| Other income and charges | |
| Profit before tax | ₹181 Cr |
| Tax | |
| Net profitNet Profit | ₹135 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹1,224 Cr |
| Equity capitalEquity Capital | ₹10 Cr |
| Reserves | ₹773 Cr |
| Borrowings | ₹292 Cr |
| Other liabilitiesOther Liabilities | ₹148 Cr |
| AssetsTotal Assets | ₹1,224 Cr |
| Fixed assetsFixed Assets | ₹672 Cr |
| Capital work in progressCWIP | ₹67 Cr |
| Investments | ₹328 Cr |
| Other assetsOther Assets | ₹157 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹207 Cr |
| Investing cash flowCash from Investing Activity | -₹165 Cr |
| Financing cash flowCash from Financing Activity | -₹47 Cr |
| Change in cashNet Cash Flow | -₹6 Cr |
Learn while you research
Academy chapters picked for Vijaya Diagnostic Centre Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 69.2, learn when high multiples are justified.6 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read